Insider Stock Trading History of Kassberg Thomas Richard


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kassberg Thomas Richard since year 2005. The trader's CIK number is 1303811. At the time of this reporting, Kassberg Thomas Richard is the CBO & Senior Vice President of Ultragenyx Pharmaceutical Inc. . (stock ticker symbol RARE). See this page for all insider trading activities at Ultragenyx Pharmaceutical Inc. .

Note that in the past Kassberg Thomas Richard also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Kassberg Thomas Richard since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-08-12 RARE Ultragenyx Pharmaceutical Inc. Sale 3,334 109.70 365,739
2015-07-08 RARE Ultragenyx Pharmaceutical Inc. Sale 3,334 102.12 340,468
2015-06-10 RARE Ultragenyx Pharmaceutical Inc. Sale 3,334 88.19 294,025
2015-05-13 RARE Ultragenyx Pharmaceutical Inc. Sale 3,334 72.04 240,181
2015-04-08 RARE Ultragenyx Pharmaceutical Inc. Sale 3,333 58.02 193,380
2015-03-11 RARE Ultragenyx Pharmaceutical Inc. Sale 3,333 56.30 187,647
2015-02-11 RARE Ultragenyx Pharmaceutical Inc. Sale 3,333 54.31 181,021
2015-01-14 RARE Ultragenyx Pharmaceutical Inc. Sale 3,333 51.51 171,682
2014-12-10 RARE Ultragenyx Pharmaceutical Inc. Sale 3,333 40.22 134,053
2014-11-12 RARE Ultragenyx Pharmaceutical Inc. Sale 3,333 41.85 139,486
2014-10-08 RARE Ultragenyx Pharmaceutical Inc. Sale 3,333 53.26 177,515
2014-09-10 RARE Ultragenyx Pharmaceutical Inc. Sale 3,333 54.82 182,715
2014-09-02 RARE Ultragenyx Pharmaceutical Inc. Sale 10,000 52.82 528,200
2014-09-03 RARE Ultragenyx Pharmaceutical Inc. Sale 10,000 55.00 550,000
2014-01-30 RARE Ultragenyx Pharmaceutical Inc. Buy 1,500 21.00 31,500
2007-12-28 ITMN Intermune Inc Sale 9,375 13.45 126,093
2007-12-28 ITMN Intermune Inc Option Ex 9,375 10.11 94,781
2007-10-10 ITMN Intermune Inc Sale 4,289 19.31 82,812
2007-10-01 ITMN Intermune Inc Option Ex 24,684 12.36 305,094
2007-10-01 ITMN Intermune Inc Option Ex 24,684 12.36 305,094
2007-07-10 ITMN Intermune Inc Sale 12,900 27.24 351,396
2007-07-09 ITMN Intermune Inc Sale 40,763 27.27 1,111,729
2007-07-10 ITMN Intermune Inc Option Ex 12,900 11.98 154,542
2007-07-09 ITMN Intermune Inc Option Ex 40,763 11.98 488,340
2007-07-06 ITMN Intermune Inc Option Ex 36,609 14.07 515,088
2007-07-06 ITMN Intermune Inc Sale 36,609 26.82 982,036
2006-11-01 ITMN Intermune Inc Sale 1,474 22.06 32,516

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kassberg Thomas Richard (CBO & Senior Vice President of Ultragenyx Pharmaceutical Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.